Safety & Regulatory Considerations BPC-157 is not approved by the U.S
More impressively, in chronic unpredictable stress models, BPC-157 maintained effectiveness at 4-day and 6-day timepoints while imipramine required prolonged treatment
Blood work including inflammatory markers (CRP, ESR), cytokine panels, and immune cell subsets can provide deeper insight into whether the protocol is modulating the underlying immune dysfunction
For pyruvate tolerance test, glycerol tolerance test and CL316432 loading test, 16-hr fasted mice were administered intraperitoneally with 1 g/kg sodium pyruvate, 0.5 g/kg glycerol and 0.1 mg/kg CL316432 (Tocris Bioscience, Bristol, UK), respectively and blood glucose levels were monitored at the indicated time points